These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Oncoapoptotic signaling and deregulated target genes in cancers: special reference to oral cancer. Khan Z; Bisen PS Biochim Biophys Acta; 2013 Aug; 1836(1):123-45. PubMed ID: 23602834 [TBL] [Abstract][Full Text] [Related]
3. Progress in targeted therapeutic drugs for oral squamous cell carcinoma. Liu L; Chen J; Cai X; Yao Z; Huang J Surg Oncol; 2019 Dec; 31():90-97. PubMed ID: 31550560 [TBL] [Abstract][Full Text] [Related]
4. Downregulation of Jumonji-C domain-containing protein 5 inhibits proliferation by silibinin in the oral cancer PDTX model. Yang CY; Tsao CH; Hsieh CC; Lin CK; Lin CS; Li YH; Chang WC; Cheng JC; Lin GJ; Sytwu HK; Wang YL; Chen YW PLoS One; 2020; 15(7):e0236101. PubMed ID: 32678829 [TBL] [Abstract][Full Text] [Related]
5. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma. Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492 [TBL] [Abstract][Full Text] [Related]
6. Cell division cycle associated 1 as a novel prognostic biomarker and therapeutic target for oral cancer. Thang PM; Takano A; Yoshitake Y; Shinohara M; Murakami Y; Daigo Y Int J Oncol; 2016 Oct; 49(4):1385-93. PubMed ID: 27499128 [TBL] [Abstract][Full Text] [Related]
7. OMICS, Oral Cancer Molecular Landscapes, and Clinical Practice. D'Souza W; Saranath D OMICS; 2017 Dec; 21(12):689-703. PubMed ID: 29173078 [TBL] [Abstract][Full Text] [Related]
8. Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma. Tsai LL; Yu CC; Chang YC; Yu CH; Chou MY J Oral Pathol Med; 2011 Sep; 40(8):621-8. PubMed ID: 21342274 [TBL] [Abstract][Full Text] [Related]
9. Differential role of microRNAs in prognosis, diagnosis, and therapy of ovarian cancer. Mahdian-Shakib A; Dorostkar R; Tat M; Hashemzadeh MS; Saidi N Biomed Pharmacother; 2016 Dec; 84():592-600. PubMed ID: 27694003 [TBL] [Abstract][Full Text] [Related]
11. Role of Salivary Biomarkers in Oral Cancer Detection. Khurshid Z; Zafar MS; Khan RS; Najeeb S; Slowey PD; Rehman IU Adv Clin Chem; 2018; 86():23-70. PubMed ID: 30144841 [TBL] [Abstract][Full Text] [Related]
12. MicroRNAs as effective surrogate biomarkers for early diagnosis of oral cancer. Cao M; Zheng L; Liu J; Dobleman T; Hu S; Go VLW; Gao G; Xiao GG Clin Oral Investig; 2018 Mar; 22(2):571-581. PubMed ID: 29299731 [TBL] [Abstract][Full Text] [Related]
13. Neuropilin-1 promotes epithelial-to-mesenchymal transition by stimulating nuclear factor-kappa B and is associated with poor prognosis in human oral squamous cell carcinoma. Chu W; Song X; Yang X; Ma L; Zhu J; He M; Wang Z; Wu Y PLoS One; 2014; 9(7):e101931. PubMed ID: 24999732 [TBL] [Abstract][Full Text] [Related]
14. Modulating effect of hesperetin on the molecular expression pattern of apoptotic and cell proliferative markers in 7,12-dimethylbenz(a)anthracene-induced oral carcinogenesis. Babukumar S; Vinothkumar V; Ramachandhiran D Arch Physiol Biochem; 2020 Dec; 126(5):430-439. PubMed ID: 30663412 [TBL] [Abstract][Full Text] [Related]
15. Metallic gold and bioactive quinacrine hybrid nanoparticles inhibit oral cancer stem cell and angiogenesis by deregulating inflammatory cytokines in p53 dependent manner. Satapathy SR; Nayak A; Siddharth S; Das S; Nayak D; Kundu CN Nanomedicine; 2018 Apr; 14(3):883-896. PubMed ID: 29366881 [TBL] [Abstract][Full Text] [Related]
16. Role of IGFBP-2 in oral cancer metastasis. Tsai YF; Chou HC; Liou MH; Liao EC; Cheng CT; Chang SJ; Chan HL Biochim Biophys Acta Mol Basis Dis; 2021 Jul; 1867(7):166143. PubMed ID: 33864954 [TBL] [Abstract][Full Text] [Related]